Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences
-
Ealixir Reports Full Year 2025 Results
-
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2026
-
Zanskar Closes $40M in Novel Development Capital Financing, structured to scale to $100M
-
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
-
EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026
-
Clarification – distribution of the press release dated Thursday 16 April 2025
-
Exodus Expands XRP and RLUSD Support, in Collaboration with Ripple
-
Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting
-
Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2026
-
MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
-
Bilibili Publishes 2025 Environmental, Social and Governance Report
-
Announcement of AGM Results
-
ATUM Welcomes Gavin Barnard, Ph.D., as Chief Scientific Officer
-
Redefining Enterprise Engagement at InnoEX Hong Kong: Aurora Mobile's EngageLab Unveils AI-First Solutions
-
CareCloud Reaffirms Guidance Following Capital Structure Simplification, Capping a Decade of Transformation
-
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
-
CoinShares Appoints Paul Grinberg as Chairman and Announces Full Board of Directors Following Nasdaq Listing
-
HRCI Introduces Its Next Chapter with a New Brand Identity
-
Eshallgo Announces 1 for 16 Share Consolidation
-
Remedy Plan Therapeutics Announces Multiple Presentations at the AACR Annual Meeting 2026
-
Abaxx to Launch World’s First Exchange-Traded Solar Futures Contract
-
Balchem Corporation Announces Quarterly Conference Call for First Quarter 2026 Financial Results on April 30, 2026
-
Soleo Health Appoints Joy Rowan as New Senior Vice President of Sales to Drive Strategic Growth Initiatives
-
Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders
-
Guardian Capital Announces April 2026 Cash Distributions for Guardian Capital ETFs
-
MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia
-
Adlai Nortye Announces $150.0 Million Private Placement Equity Financing
-
Cielo Closes Strategic Asset Acquisition and Announces Intention to Appoint Chief Operating Officer and Chief Development Officer
-
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
-
Nula Therapeutics Launches with up to $20 Million ARPA-H Award to Advance a New Class of Medicines Targeting the Nuclear Envelope of Cells
-
Canadian Premium Sand Inc. Announces Strategic Review
-
Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Niche Announces Collaboration with Huron to Bring Real-Time Market Intelligence to Enrollment and Financial Aid Strategy
-
Man Group PLC : Form 8.3 - JTC Plc
-
Man Group PLC : Form 8.3 - Bluefield Solar Income Fund Ltd
-
Man Group PLC : Form 8.3 - A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
-
Coop Pank AS will hold an investor webinar to introduce the results for the Q1 2026
-
Eton Pharmaceuticals Announces CFO Succession Plan
-
Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain
-
DT Midstream to Announce First Quarter 2026 Financial Results, Schedules Earnings Call
-
BOSS Zhipin's Sustained Share Repurchases Achieved Nearly RMB880 Million in 2026
-
Safe Harbor Financial Fourth Quarter and Full Year 2025 Results, Highlighting Sequential 12% Sales Growth, Balance Sheet Transformation and Operational Progress
-
FTAI Infrastructure Inc. Announces Timing of First Quarter 2026 Earnings and Conference Call
-
Kraken Robotics Reports 2025 Financial Results
-
CNH to announce 2026 Q1 results on April 30
-
Zacatecas Silver Completes Surface Sampling and Mapping Program at Oso Negro Project, Sonora, Mexico
-
BOSS Zhipin's Sustained Share Repurchases Achieved Nearly RMB880 Million in 2026
-
BiomedVC Adds Three Renowned Entrepreneurs as Advisors for Fund IV to Champion Early-Stage European Biotech

